PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW
Maria Luisa Moleti, Anna Maria Testi
it (code pays fourni par la source)
11 citations
Mediterranean Journal of Hematology and Infectious Diseases
Maria Luisa Moleti
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
119Publications signalées
1485Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Acute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research
Les publications récentes
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ.
Anna Maria Testi, Mazin Faisal Al‐Jadiry, Maria Luisa Moleti, Stefania Uccini et autres
it, iq (code pays fourni par la source)
2 citations
Mediterranean Journal of Hematology and Infectious Diseases
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies
Francesco Malfona, Anna Maria Testi, Sabina Chiaretti, Maria Luisa Moleti
it (code pays fourni par la source)
13 citations
Blood and Lymphatic Cancer Targets and Therapy
ACUTE LYMPHOBLASTIC LEUKAEMIA OCCURRED 21 YEARS AFTER A FIRST DIAGNOSIS IN A DOWN SYNDROME PATIENT SUCCESFULLY TREATED WITH BLINATUMOMAB
Lorenzo Rizzo, Sabina Chiaretti, Irene Della Starza, Akram Taherinasab et autres
it (code pays fourni par la source)
0 citations
TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN IRAQ: A 17-YEAR EXPERIENCE FROM A SINGLE CENTER
Salma A. Al‐Hadad, Mazin Faisal Al‐Jadiry, Hasanein H. Ghali, Raghad Majid Al‐Saeed et autres
iq, it (code pays fourni par la source)
0 citations
S215: KEYNOTE-667: OPEN-LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY
Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli et autres
it, gb, es, nl, fr, cz, de, us (code pays fourni par la source)
2 citations
HemaSphere
Efficacy and safety of pembrolizumab (pembro) in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo) in the phase 2, open-label, KEYNOTE-667 study.
Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli et autres
it, gb, es, nl, fr, cz, de, us (code pays fourni par la source)
4 citations
Journal of Clinical Oncology
PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY
Luciana Vinti, Stephen Daw, Franca Fagioli, Auke Beishuizen et autres
it, gb, es, nl, fr, cz, de, us (code pays fourni par la source)
1 citation
Hematological Oncology
Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review
Anna Maria Testi, Maria Luisa Moleti, Alessia Angi, Simona Bianchi et autres
it (code pays fourni par la source)
9 citations
Pediatric Health Medicine and Therapeutics
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study
Alessandra Micozzi, Clara Minotti, Saveria Capria, Claudio Cartoni et autres
it (code pays fourni par la source)
11 citations
Infection and Drug Resistance
P089: Pembrolizumab in Pediatric and Young Adults Patients With Newly Diagnosed Classical Hodgkin Lymphoma and Slow Early Responders to Frontline Chemotherapy: The Phase 2 KEYNOTE-667 Study
Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli et autres
it, gb, es, nl, fr, cz, de, us (code pays fourni par la source)
0 citations
HemaSphere
An unusual myositis presentation in a pediatric patient with sickle cell disease
Michela Ribersani, Anna Maria Testi, Giovanna Palumbo, Carla Giordano et autres
it (code pays fourni par la source)
1 citation
Pediatric Blood & Cancer
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.